GHP Investment Advisors Inc. Cuts Stock Holdings in Encompass Health Co. (NYSE:EHC)

GHP Investment Advisors Inc. lessened its holdings in Encompass Health Co. (NYSE:EHC) by 3.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,792 shares of the company’s stock after selling 695 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Encompass Health were worth $1,735,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CIBC Asset Management Inc boosted its stake in shares of Encompass Health by 3.5% in the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock valued at $286,000 after buying an additional 100 shares in the last quarter. Miracle Mile Advisors LLC lifted its holdings in Encompass Health by 3.0% in the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after acquiring an additional 112 shares during the period. MassMutual Private Wealth & Trust FSB grew its stake in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares during the period. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Finally, Verdence Capital Advisors LLC lifted its stake in shares of Encompass Health by 4.6% in the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock valued at $355,000 after purchasing an additional 160 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on EHC shares. KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Barclays lifted their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday. StockNews.com downgraded Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Royal Bank of Canada increased their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. One analyst has rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health currently has an average rating of “Buy” and a consensus target price of $107.33.

Encompass Health Trading Up 1.3 %

Shares of EHC stock opened at $99.86 on Friday. The company has a market capitalization of $10.06 billion, a price-to-earnings ratio of 24.12, a PEG ratio of 1.18 and a beta of 0.90. Encompass Health Co. has a twelve month low of $72.37 and a twelve month high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a 50-day moving average price of $96.28 and a 200 day moving average price of $95.19.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Research analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.